Andrew Tucker
About Andrew Tucker
Andrew Tucker is a Senior Scientist in Vector Biology at Sana Biotechnology, Inc., where he focuses on developing innovative gene and cell therapies. He has a strong background in vector biology, with experience in research roles at various institutions and multiple publications in prestigious journals.
Current Role at Sana Biotechnology
Andrew Tucker currently serves as a Senior Scientist in Vector Biology at Sana Biotechnology, Inc., a position he has held since 2023. In this role, he focuses on developing innovative gene and cell therapies aimed at addressing unmet medical needs. His work involves designing and executing complex experiments, as well as collaborating with cross-functional teams and external partners to advance scientific projects.
Previous Experience in Research
Prior to his current role, Andrew Tucker has accumulated extensive research experience across various institutions. He worked as a Research Assistant at the University of Toledo from 2010 to 2011. He then served as a Research Scientist at the University of Washington from 2011 to 2014, followed by a position at Seattle Children's Hospital from 2014 to 2016. Additionally, he worked at the Allen Institute for Cell Science as a Research Associate from 2016 to 2019 and returned to Sana Biotechnology as a Principal Research Associate from 2019 to 2020.
Educational Background
Andrew Tucker earned a Bachelor of Science degree in Biology from The University of Toledo, studying from 2009 to 2011. He also studied Cell/Cellular and Molecular Biology at Grand Valley State University from 2008 to 2010, where he obtained another Bachelor of Science degree. His educational background has provided him with a solid foundation in biological sciences, which supports his research in vector biology.
Publications and Presentations
Andrew Tucker has co-authored multiple publications in prestigious journals, specifically in the field of Cell and Gene Therapy. He has also presented data at various conferences, showcasing his expertise and contributions to the field. His work in research has been recognized within the scientific community, reflecting his commitment to advancing knowledge in gene and cell therapies.